Dermatitis Herpetiformis Refractory to Gluten Free Diet
- Conditions
- Dermatitis Herpetiformis
- Interventions
- Other: Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
- Registration Number
- NCT05998291
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
The main purpose of the study is to find out
1. the natural course of refractory dermatitis herpetiformis and the development of possible complications
2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis
- Detailed Description
Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and prognosis of refractory celiac disease.
Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 23
Study patients:
- Dermatitis herpetiformis diagnosis
- Dermatitis herpetiformis rash not responding to a strict gluten-free diet after at least 3 years
Control patients:
- Dermatitis herpetiformis diagnosis
- Dermatitis herpetiformis with good response to a gluten-free diet
Study patients:
-Not following strict gluten-free diet
Control patients:
-Not following a strict gluten-free diet
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Refractory dermatitis herpetiformis patients Assessment of prognosis of refractory dermatitis herpetiformis. No intervention Dermatitis herpetiformis rash not controlled by strict glute-free diet Dermatitis herpetiformis patients with good response to gluten-free diet Assessment of prognosis of refractory dermatitis herpetiformis. No intervention Dermatitis herpetiformis rash controlled by strict glute-free diet
- Primary Outcome Measures
Name Time Method Clinical prognosis Baseline Occurrence of complications
- Secondary Outcome Measures
Name Time Method Dietary adherence GIP test, CDAT, TG2, TG3 and Ema antibodies, anamnesis Baseline The strictness of gluten-free diet (GIP test)
Trial Locations
- Locations (1)
Tampere University Hospital
🇫🇮Tampere, Finland